Clopidogrel (PLAVIX) increases risk of bleeding in a patient undergoing coronary artery bypass grafting.
Hirose
Hitoshi
H
D016063:Blood Loss, Surgical / Q000706:statistics & numerical data; D001803:Blood Transfusion / Q000706:statistics & numerical data; D000077144:Clopidogrel; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019106:Postoperative Hemorrhage / Q000209:etiology* / Q000601:surgery; D018570:Risk Assessment; D012307:Risk Factors; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine